Chemotherapy wafer to treat oral cancer topically
Privo Technologies, MA, United States
Our ChemoThin Wafer (CTW) is a polymeric mesh that hold chemotherapy nano-particles. upon hydration, it releases the nano particles along with other excipients directly into the tumor. The CTW is unidirectional mucoadhesive wafer that remain in place and can be removed after one hour of appliction.
Primary Application Area: Biotech & Biological Sciences
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
FIGURES OF MERIT
Value Proposition: Our wafer is intended to be placed topically directly on the tumor in the oral cavity. It has shown very promising results in our in-vivo studies. The results show high efficacy due to high concentration of the anit-cancer drug in the tumor with limited systemic exposure and side effects.
Organization Type: Early-stage Startup (Seed)
Showcase Booth #: 51T
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date:
Primary Sources of Funding: Angel, Friends, Family, Corporate Partner, Federal Grant
Looking for: Both Funding and Development Partners